CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: brompheniramine
Accession: CHEBI:3183
browse the term
Definition: Pheniramine in which the hydrogen at position 4 of the phenyl substituent is substituted by bromine. A histamine H1 receptor antagonist, brompheniramine is used (commonly as its maleate salt) for the symptomatic relief of allergic conditions, including rhinitis and conjunctivitis.
Synonyms: related_synonym: 1-(p-bromophenyl)-1-(2-pyridyl)-3-dimethylaminopropane; 2-(p-bromo-alpha-(2-dimethylaminoethyl)benzyl)pyridine; 3-(4-bromophenyl)-N,N-dimethyl-3-(2-pyridinyl)-1-propanamine; 3-(4-bromophenyl)-N,N-dimethyl-3-(pyridin-2-yl)propan-1-amine; 3-(p-bromophenyl)-3-(2-pyridyl)-N,N-dimethylpropylamine; [3-(4-Bromo-phenyl)-3-pyridin-2-yl-propyl]-dimethyl-amine; bromfeniramina; brompheniraminum
alt_id: CHEBI:154051
xref: Beilstein:217066; CAS:86-22-6; DrugBank:DB00835
xref_mesh: MESH:D001977
xref: Patent:US2567245; Patent:US2676964; drugcentral:408; kegg.compound:C06857; kegg.drug:D07543; lincs.smallmolecule:LSM-1736; pubmed:2570152; pubmed:2579237; pubmed:6458703; pubmed:9526560; wikipedia.en:Brompheniramine
chemrof_formula: C16H19BrN2
chemrof_smiles: CN(C)CCC(c1ccc(Br)cc1)c1ccccn1
chemrof_inchi: InChI=1S/C16H19BrN2/c1-19(2)12-10-15(16-5-3-4-11-18-16)13-6-8-14(17)9-7-13/h3-9,11,15H,10,12H2,1-2H3
chemrof_inchikey: ZDIGNSYAACHWNL-UHFFFAOYSA-N
G
Abcb4
ATP binding cassette subfamily B member 4
decreases activity
ISO
Brompheniramine results in decreased activity of ABCB4 protein
CTD
PMID:28437613
NCBI chr 4:26,106,895...26,164,440
G
Kcnh2
potassium voltage-gated channel subfamily H member 2
decreases activity
ISO
Brompheniramine results in decreased activity of KCNH2 protein
CTD
PMID:17010640 PMID:17516459
NCBI chr 4:11,719,357...11,751,424
Ensembl chr 4:11,692,980...11,751,421
G
Scn5a
sodium voltage-gated channel alpha subunit 5
decreases activity
ISO
Brompheniramine results in decreased activity of SCN5A protein
CTD
PMID:17010640
NCBI chr 8:128,098,613...128,196,515
Ensembl chr 8:128,098,613...128,196,470
G
Slc22a2
solute carrier family 22 member 2
multiple interactions
ISO
Brompheniramine inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium]
CTD
PMID:21599003
NCBI chr 1:50,668,817...50,711,019
Ensembl chr 1:50,668,817...50,711,019
G
Kcnh2
potassium voltage-gated channel subfamily H member 2
decreases activity
ISO
dexbrompheniramine results in decreased activity of KCNH2 protein
CTD
PMID:28551711
NCBI chr 4:11,719,357...11,751,424
Ensembl chr 4:11,692,980...11,751,421
G
Slc22a2
solute carrier family 22 member 2
multiple interactions
ISO
dexbrompheniramine inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium]
CTD
PMID:21599003
NCBI chr 1:50,668,817...50,711,019
Ensembl chr 1:50,668,817...50,711,019
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all